NEW YORK, July 7, 2026
Regal Healthcare Capital Partners has successfully completed the final close of Fund IV, securing $610 million in total commitments, surpassing its original fundraising target of $550 million. The healthcare-focused private equity firm raised approximately $575 million from external investors, reflecting strong institutional confidence in its investment strategy focused exclusively on healthcare services companies. Since its inception, Regal has now raised nearly $1.3 billion across its first four investment funds, strengthening its position as a leading healthcare private equity investor dedicated to partnering with innovative healthcare entrepreneurs throughout the United States. The successful fundraising demonstrates continued investor interest in the healthcare sector, driven by increasing demand for high-quality healthcare delivery, expanding patient access, and long-term growth opportunities across healthcare services. Fund IV will enable Regal to continue investing in lower-middle-market healthcare companies while supporting operational growth, strategic expansion, and value creation across the healthcare ecosystem.
Fund IV Attracts Strong Institutional Investor Support
Regal’s Fund IV received significant backing from both existing limited partners and a broad group of new institutional investors, expanding the firm’s investor base across multiple regions and investor categories. The fund attracted commitments from leading endowments, foundations, public pension plans, global asset managers, and investment consultants, highlighting widespread confidence in Regal’s disciplined healthcare investment strategy. According to David Kim, M.D., General Partner at Regal, the successful fundraising reflects the quality of the firm’s long-standing investor relationships and the continued confidence investors have in Regal’s ability to identify attractive opportunities within the healthcare services sector.
Jon Santemma, General Partner, added that the successful close positions the firm to capitalize on new investment opportunities while continuing to support healthcare entrepreneurs seeking strategic capital and operational expertise. The fundraising process was supported by Lazard as exclusive placement agent, while Kirkland & Ellis served as legal counsel throughout the transaction.
Healthcare Investment Strategy Supports Industry Growth
Advertisement
Regal Healthcare Capital Partners focuses exclusively on lower-middle-market healthcare services companies, investing in organizations that improve patient access, quality of care, and operational efficiency across the U.S. healthcare system. Through Fund IV, the firm plans to continue making equity investments of approximately $75 million in healthcare businesses, primarily targeting companies generating $20 million to $100 million in annual revenue with strong growth potential. The healthcare services sector continues to attract significant private equity investment due to favorable demographic trends, increasing healthcare utilization, ongoing digital transformation, and demand for innovative care delivery models.
By partnering closely with experienced healthcare management teams, Regal aims to accelerate business expansion, strengthen operational performance, and improve healthcare accessibility while generating long-term value for investors. The successful oversubscription of Fund IV further reinforces confidence in the resilience of healthcare investments and highlights continued institutional appetite for specialized healthcare private equity strategies. As healthcare organizations continue evolving to meet changing patient needs and industry demands, Regal Healthcare Capital Partners is well positioned to support the next generation of healthcare service providers through strategic capital, operational guidance, and long-term investment expertise, contributing to continued innovation and sustainable growth across the healthcare industry.
Source: Regal Healthcare Capital Partners press release
